Scout | Funding for new strategies to accelerate drug development in ultra-rare cancers

forecast

Funding for new strategies to accelerate drug development in ultra-rare cancers

This program supports innovative, early-stage efforts to speed therapeutic development for ultra-rare pediatric and adult cancers, including molecular subtypes of more common diseases. Proposed work may include building patient data infrastructure, defining new early clinical endpoints, using real-world data registries, repurposing or re-enabling discontinued drugs, and improving trial access …

Source

Agency: Food and Drug Administration

Eligibility

government

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

ultra-rare cancers

pediatric oncology

drug development

real-world data

clinical endpoints

telemedicine trials

nanoparticle delivery

single-cell proteomics

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers